000			01736 a2200445 4500
005			20250511202019.0
264		0	_c19920124
008			199201s 0 0 eng d
022			_a0006-291X
024	7		_a10.1016/0006-291x(91)91277-j _2doi
040			_aNLM _beng _cNLM
100	1		_aRoth, B V
245	0	0	_aMutants of human insulin-like growth factor II: expression and characterization of analogs with a substitution of TYR27 and/or a deletion of residues 62-67. _h[electronic resource]
260			_bBiochemical and biophysical research communications _cDec 1991
300			_a907-14 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aBase Sequence
650	0	4	_aBinding Sites
650	0	4	_aCarrier Proteins _xmetabolism
650	0	4	_aChromatography, Affinity
650	0	4	_aChromatography, High Pressure Liquid
650	0	4	_aCyanogen Bromide
650	0	4	_aDNA _xbiosynthesis
650	0	4	_aEscherichia coli _xgenetics
650	0	4	_aGene Expression
650	0	4	_aHumans
650	0	4	_aInsulin-Like Growth Factor Binding Proteins
650	0	4	_aInsulin-Like Growth Factor II _xanalogs & derivatives
650	0	4	_aMolecular Sequence Data
650	0	4	_aMutagenesis, Site-Directed
650	0	4	_aReceptors, Cell Surface _xmetabolism
650	0	4	_aReceptors, Somatomedin
650	0	4	_aRecombinant Fusion Proteins _xbiosynthesis
650	0	4	_aStaphylococcal Protein A
700	1		_aBürgisser, D M
700	1		_aLüthi, C
700	1		_aHumbel, R E
773	0		_tBiochemical and biophysical research communications _gvol. 181 _gno. 2 _gp. 907-14
856	4	0	_uhttps://doi.org/10.1016/0006-291x(91)91277-j _zAvailable from publisher's website
999			_c1728213 _d1728213